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RESUM
La proteïna transportadora de les hormones sexuals (SHBG) va ser descrita a finals dels anys
seixanta amb les funcions de transportar els esteroides sexuals i de regular-ne la biodisponibili-
tat. Des de fa ja bastant temps, es coneix també que les cèll. ules testiculars de Sertoli expressen la
proteïna que lliga els andrògens (androgen-binding protein oABP), que està codificada pel mateix
gen que la SHBG, però glicosilada diferentment. Les funcions de l’ABP han estat àmpliament
estudiades, i actualment se sap ja que l’ABP és un dels reguladors locals de l’espermatogènesi.
Nogensmenys, la presència de la SHBG en l’ovari ha estat molt poc estudiada. L’objectiu del
present article és el de revisar el que actualment es coneix sobre l’expressió de la SHBG en la
gònada femenina, incloent-hi les troballes recents del nostre grup que demostren la presència
de la SHBG en els foll. icles ovàrics, particularment en el citoplasma de les cèll. ules de la granu-
losa, en algunes cèll. ules de la teca i en els oòcits de foll. icles primordials, primaris i secundaris, i
també en el cos luti. A més, l’expressió del gen de la SHBG s’ha evidenciat també en les cèll. ules
granulosoluteíniques en pacients sotmeses a fertilització in vitro. Això suggereix que aquestes
cèll. ules constitueixen una font local de SHBG en l’ovari humà. Aquestes noves dades sugge-
reixen la implicació de la SHBG en la fisiologia ovàrica.Paraules clau: proteïna transportadora de les hormones sexuals (SHBG), ovari, cos luti, fluid
foll. icular.
SUMMARY
Sex hormone-binding globulin (SHBG) was described in the late sixties as a hepatic carrier
protein for sex steroids and was thought to regulate their bio-availability. It has also been known
for many years that testicular Sertoli cells express androgen-binding protein (ABP), which is
encoded by the same gene as SHBG, but which is differentially glycosylated. The possible roles
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of ABP have been extensively studied, and this protein may be one of the local regulators of
spermatogenesis. In contrast, very few authors have investigated the presence of SHBG in the
ovary. The aim of the present paper is to provide a survey of what is currently known about
the expression of SHBG in the female gonad, including our own recent findings that SHBG
was present in ovarian follicles. This was true, particularly in the cytoplasm of granulosa cells,
some theca cells, and oocytes in primordial, primary, and early secondary follicles, as well as
in the corpus luteum. Furthermore, the expression of the SHBG gene has been demonstrated
in granulosa-lutein cells from in vitro fertilization patients, indicating that these cells are one
of the local sources of SHBG in the human ovary. These new data suggest an involvement of
SHBG in ovarian physiology.Keywords: sex hormone-binding globulin (SHBG), ovary, corpus luteum, follicular fluid.
INTRODUCTION
Sex hormone-binding globulin (SHBG) was
classically thought to originate in the liver
and was believed to carry steroid hormones
in blood serum, especially dihydrotestos-
terone, testosterone, and estradiol (Joseph,
1994). Thus, the main function of SHBG was
considered to be the regulation of their bio-
availability, according to the free hormone
theory, which postulated that only the free
and unbound fraction of steroids would be
able to cross the cell membrane and inter-
act with their intracellular receptors (Siiteri
et al., 1982; Mendel, 1989). A homologous
but differentially glycosylated protein, called
androgen-binding protein (ABP), was known
to be produced in the testis by Sertoli cells
and to be secreted into the seminiferous
tubules (French and Ritzen, 1973; Hagenas et
al., 1975), where it was believed to regulate the
local concentration of androgens.
Over the last twenty years this basic concept
of a steroid-carrying protein has been ques-
tioned because of several major discoveries:
first, SHBG is expressed in several sites other
than the liver and testis, especially in steroid-
sensitive tissues, such as the prostate, fallop-
ian tube, and mammary gland (reviewed in
Joseph, 1994); and, second, in most of these
tissues, SHBG specifically binds to the cell
membrane (Strel’chyonok et al., 1984; Hryb
et al., 1985; Fortunati et al., 1991; Frairia et
al., 1991). This phenomenon has been con-
sidered to be receptor-mediated, but until
now the molecular characteristics of the puta-
tive SHBG receptor had not been determined.
Nevertheless, membrane-bound SHBG has
been shown to induce an increase in intra-
cellular cAMP (Rosner, 1990), which is even
more augmented after the secondary binding
of a steroid hormone to the SHBG-receptor
complex (Hryb et al., 1990). Another impor-
tant finding concerned an alternative splicing
process for the SHBG mRNA, yielding sev-
eral transcript variants, in addition to the full
length transcript that included eight exons
with the first exon encoding the secretion sig-
nal (Gershagen et al., 1989; Hammond et al.,
1989; Sullivan et al., 1991, 1993). However,
until now the function of the corresponding
modified proteins had not been elucidated.
Taken together, these data strongly suggest
that SHBG is more than a simple transport
protein and that it may have much broader
functions in cell biology, possibly as a hor-
mone or as a locally active auto- or paracrine
factor. Thus, it may play a regulatory role in
the physiology of sex steroid-sensitive tissues.
It has been suggested that ABP is involved in
the local control of spermatogenesis, particu-
larly in the testis (Gerard, 1995; Gerard et al.,
1996; Della-Maria et al., 2002). Whereas the ex-
pression and function of testicular ABP have
given rise to a large amount of scientific work,
curiously, the presence and possible involve-
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ment of SHBG in the female gonad have not
been extensively investigated. The present pa-
per proposes a systematic review of what is
currently known about ovarian SHBG expres-
sion.
SHBG IN FOLLICULAR FLUID
In the ovary, the presence of SHBG was
originally detected in the ovarian follicular
fluid. It has been known for a long time that
the total protein concentration of follicular
fluid is similar to or slightly lower than that
of blood serum (Perloff et al., 1954; Zachariae
and Jensen, 1958; Shalgi et al., 1972). Thus,
most of the serum proteins are also present
in follicular fluid (Shalgi et al., 1973). In one
study, however, the author found a follicular
fluid protein concentration only half that of
serum (Edwards, 1974), which could be ex-
plained by the different maturation degree of
the punctured follicles. The latter hypothesis
is consistent with results from another group,
who showed follicular fluid protein compo-
sition to become progressively more similar
to that of blood serum as the follicle grew
up to the pre-ovulatory stage (DiZerega et al.,
1983).
Initially, a protein binding to dihydrotestos-
terone (DHT) and estradiol was detected in
the follicular fluid from three patients with
polycystic ovary disease, who underwent
a transvaginal puncture for ovarian cysts
(Vigersky and Loriaux, 1976). This protein had
high affinity and low capacity, as well as elec-
trophoretical properties identical to those of
serum SHBG. Later, SHBG and corticosteroid-
binding globulin (CBG) were clearly identi-
fied in the antral fluid of pre-ovulatory folli-
cles in healthy volunteers (Martin et al., 1981).
With the development of in vitro fertiliza-
tion (IVF) techniques, follicular fluid became
an easily available material, which has been
extensively studied since then. The follicular
concentration of SHBG in IVF patients was
found to be similar to that of blood serum,
and there was a significant correlation be-
tween follicular and serum level s (Ben-Rafael
et al., 1986). This result was later confirmed
by Andersen, who described remarkably sta-
ble SHBG concentrations within the differ-
ent follicles of the same patient (Andersen,
1990). In contrast, another group detected im-
portant variations in the SHBG concentra-
tion, with some follicles having a higher con-
centration and others a lower one than in
the blood serum (Campo et al., 1989). Other
authors explained the absence of any cor-
relation between follicular fluid and serum
SHBG concentrations as a possible effect of
gonadotrophin releasing hormone agonists,
which had not been used in the previous stud-
ies (Phocas et al., 1995). Anyway, at that time
the only known source of SHBG was the liver
and testis, thus, follicular fluid SHBG was
thought to originate exclusively in the blood,
crossing the blood-follicle barrier quite easily,
due to its molecular weight of about 90 kD.
As to the possible role of SHBG in follicu-
lar fluid, there have been several hypotheses,
all of them based on the steroid-binding prop-
erties of the protein. Thus, follicular SHBG
could play a role by trapping steroids within
the follicle (Edwards, 1974), regulating the
bio-availability of steroids, in the follicle, es-
pecially estradiol (Baird and Fraser, 1975), and
controlling the transport of estradiol into or
out of the follicle (Younglai and Short, 1970;
Steinglod et al., 1988). However, these classi-
cal concepts need to be questioned, as it has
been shown that estradiol concentration in the
fluid of pre-ovulatory follicles is about 1,000
times higher than in the serum, and there-
fore, exceeds the binding capacity of SHBG
20 to 100 fold (McNatty, 1978; Martin et al.,
1981; Ben-Rafael et al., 1986). Actually, intra-
follicular estradiol is bound to proteins at a
rate of about 95%, while the SHBG-bound
fraction only accounts for 1.5 to 25% (O’Brien
et al., 1982; Ben-Rafael et al., 1986; Ander-
sen, 1991). Thus, other binding proteins, such
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as albumin, must be involved in maintain-
ing these very high estradiol concentrations
within the ovarian follicle. Finally, the 5% of
free estradiol still represents a high concen-
tration (10–7 M), compared to the dissociation
constant of the estradiol receptor (10–9 M).
Therefore, it is unlikely that SHBG regulates
steroid bio-availability in the follicle, as it was
classically thought to do in the serum (Martin
et al., 1981; Ben-Rafael et al., 1986).
OVARIAN SHBG IN ANIMAL MODELS
At the time when steroid-binding activi-
ties were first detected in human follicular
fluid, some authors found a similar activity
in bovine antral fluid (Andersen et al., 1976;
Cook et al., 1977) and ovine follicles (Cook
et al., 1977; Campo et al., 1985). However,
no such activity could be detected in porcine
follicles; this was considered to be indirect
proof that intra-follicular SHBG was serum-
derived, since pigs also lack serum SHBG
(Cook et al., 1977).
In the ewe, Campo et al. detected a testos-
terone and DHT-binding activity, not only in
serum and follicular fluid, but also in the cy-
tosolic fraction of the granulosa cells. In all
of the three sites, association and dissociation
constants were identical to those of testicular
ABP (Campo et al., 1985). Curiously, this inter-
esting observation did not give rise to further
investigations.
In his exhaustive review of the literature,
Joseph reported unpublished results show-
ing the presence of immunoreactive ABP in
rat granulosa and theca cells, as well as the
Northern blot detection of ABP mRNA in tis-
sue extracts from rat ovaries (Joseph, 1994).
The expression of SHBG was further in-
vestigated using transgenic mice carrying ei-
ther a rat ABP or a human SHBG trans-
gene. In the first of these models, North-
ern blot analysis revealed the presence of
rat ABP transcripts in whole ovarian ex-
tracts, while there was no expression in the
wild-type ovaries (Joseph et al., 1997). How-
ever, wild-type ovaries were shown to contain
endogenous mouse ABP transcripts. Semi-
quantitative analysis of these results demon-
strated an increasing expression from the age
of fourteen days up to the adult stage. Further-
more, ovarian extracts from transgenic mice
showed a five-fold binding activity to tritiated
DHT, when compared with wild-type ovarian
extracts. Similar results were obtained from
blood plasma and uterine extracts (Joseph et
al., 1997).
In contrast to the results from the North-
ern blot and binding assays, the ABP pro-
tein could not be localized by immunohisto-
chemistry in either transgenic or in wild-type
ovaries. To explain these discrepancies, au-
thors suggested that the Northern blots were
contaminated by mesonephrotic RNA and
that the steroid-binding activity was, in fact,
due to the follicular fluid. Nevertheless, the
possibility of a local synthesis of ABP, in ad-
dition to its uptake from the blood could not
be excluded.
Female transgenic mice presented with a
lower body weight than the wild-type ani-
mals. They also showed important neurologi-
cal disorders in their hind limbs and impaired
fertility, with a diminished number of siblings
and sometimes complete sterility. Finally, they
frequently developed tumors of the pituitary,
uterus, and ovary (Joseph et al., 1997).
As far as the second model is concerned,
that of transgenic mice carrying a human
SHBG transgene, there is no published data on
females, and regarding the males, normal fer-
tility was observed despite very high serum
SHBG and testosterone levels (Janne et al.,
1998; Janne et al., 1999).
SHBG TRANSCRIPTS
IN THE HUMAN OVARY
Twenty years ago, Ito and co-workers de-
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monstrated the presence of a steroid-binding
protein, similar to ABP, in the cytosolic frac-
tion of human ovarian cortex extracts. The
concentration of this protein was lower in
ovaries from women with polycystic ovary
syndrome than in normal ovaries (Ito et al.,
1985).
Using RT-PCR, Misao’s team demonstrated
the presence of SHBG extracts in whole ovar-
ian extracts from fifteen patients between
the ages of 25 and 68 years, who under-
went an ovariectomy for various medical
reasons (Misao et al., 1995). Their semi-quan-
titative approach, using an internal standard,
demonstrated higher expression levels in pre-
menopausal ovaries than in post-menopausal
ovaries, suggesting the possible regulatory
effect of steroid hormones on the expres-
sion of SHBG. Alternatively, it could have
been hypothesized that SHBG was predom-
inantly expressed in functional ovarian folli-
cles, which disappear after menopause. Later,
the same group demonstrated the presence
of SHBG transcripts in human corpus luteum
extracts from fifteen patients. Extracts from
the early, mid-, and late luteal phases did not
show any significant differences in the ex-
pression level (Misao et al., 1997). However
this level seemed to be positively correlated
with the serum estradiol and the serum estra-
diol/progesterone ratio (Misao et al., 1999b).
These authors also investigated SHBG ex-
pression in 34 ovarian tumors, comprising
22 malignant and 12 benign tumors. In all
cases, SHBG transcripts were detected by RT-
PCR, and the expression level did not show
any correlation to the type of tumor or the
stage of the disease. However, SHBG was
over-expressed in six of the malignant tumors;
three of them were endometrioid adenocarci-
noma (Misao et al., 1995). Actually, the pres-
ence of an estradiol-binding protein in ovarian
cancer extracts had already been described
ten years earlier using a cytochemical tech-
nique (Wand et al., 1985). In metastatic ovarian
cancers, Misao and co-workers found SHBG
transcripts in only four out of ten samples
(Misao et al., 1999a). In normal, as well as in
pathological ovarian tissues, alternative tran-
scripts lacking exon 7 were also detected, but
their proportion was higher in ovarian cancers
than in normal ovaries (Misao et al., 1998).
In a recent paper, we confirmed the re-
sults from Misao, showing the presence of
full-length SHBG transcripts, as well as splic-
ing variants lacking exon 7 in whole ovar-
ian extracts (Forges et al., 2005). We further
determined granulosa-lutein cells to be one
of the possible cellular origins of this ovar-
ian SHBG expression (Forges et al., 2004). In
that study, we collected granulosa-lutein cells
from patients, who underwent follicular as-
piration for in vitro fertilization. Total RNA
was extracted from freshly isolated cells, as
well as after a 4 day culture period. In both
cases, RT-PCR analysis showed the presence
of full-length mRNA, whereas in our study, al-
ternative transcripts could not be detected. We
thus concluded that at least the complete, se-
creted SHBG protein arose from this cell type
in the ovary. Recently, we demonstrated the
secretion of SHBG by granulosa-lutein cells
in vitro, using the Western blot analysis of the
supernatant culture media (unpublished re-
sults).
IMMUNOHISTOCHEMICAL
LOCALIZATION OF SHBG
IN THE HUMAN OVARY
Except for the above-mentioned transgenic
model, until very recently the presence of
SHBG has not been immunohistochemically
investigated in ovarian tissues. In our previ-
ous study, we showed a positive SHBG im-
munostaining in the cytoplasm of granulosa-
lutein cells from IVF patients, which was
consistent with the results of the RT-PCR
analysis, demonstrating that these cells actu-
ally produced SHBG in the ovary (Forges et
al., 2004). However, the possibility of a simul-
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taneous uptake of extra-cellular (i.e., follicular
fluid) SHBG, as it has been described in rat
Sertoli cells (Gerard et al., 1994), could not be
completely ruled out.
In another study, we performed immuno-
histochemistry on paraffin-embedded tissue
sections from human adult and fetal ovaries
(Forges, et al., 2005). SHBG immunostaining
was differentially localized throughout fol-
liculogenesis. In all stages, from primordial
follicles up to the pre-ovulatory follicle, the
cytoplasm in the granulosa cells contained
immunoreactive SHBG. This was consistent
with our previous results in granulosa-lutein
cells from stimulated ovaries. In contrast to
the granulosa layer, where nearly all of the
cells contained immunoreactive SHBG, the
theca interna of the preantral and antral stages
presented with only a few isolated, positively
stained cells.
Moreover, SHBG was present in the oocyte
cytoplasm of primordial, primary, and some
early secondary follicles, in both adult and
fetal ovaries. In contrast, from the late sec-
ondary, preantral follicle up to the graafian
follicle, the oocyte was always devoid of any
SHBG immunostaining. Thus, the presence
of SHBG in the oocyte ceased at the time
that the follicle became sensitive to FSH; but,
whether there was a causal relationship be-
tween the two phenomena or if this was a sim-
ple coincidence still needs to be determined.
To analyze the presence of SHBG in mature
human oocytes, oocyte-cumulus complexes
(OCCs) were obtained by follicular aspira-
tion from patients, who underwent ovulation
induction for intrauterine insemination and
who presented with a multi-follicular ovar-
ian response. In these patients, aspiration of
the excessive follicles was performed before
insemination, in order to avoid multiple preg-
nancies. In the OCCs, only the cumulus cells
showed immunostaining, whereas the oocyte
cytoplasm and the first polar body of the
mature oocytes were negative. Interestingly,
there was strong staining at the oocyte sur-
face and in the perivitelline space, though not
in the zona pellucida. This observation led to
the hypothesis that there existed a local accu-
mulation of SHBG, secreted by the granulosa
cells, and a subsequent interaction with SHBG
receptors on the oocyte membrane. SHBG-
binding on the oocyte surface could either be
followed by an internalization of the SHBG-
receptor complex, as had been shown by our
team in male germ cells (Gerard, 1995), or
by the production of cAMP as a second mes-
senger, which has been described in prostate
(Nakhla et al., 1990; Nakhla et al., 1994) and
breast cancer cells (Fissore et al., 1994; Fortu-
nati et al., 1999). Cyclic nucleotides actually
play an important role in the regulation of
oocyte meiotic maturation (Conti et al., 2002).
Thus, SHBG may be secreted locally by cu-
mulus cells and be involved in the control
of meiotic arrest. However, the presence of
SHBG-specific binding sites on the oolemma
has not yet been investigated.
In ovarian tissue sections containing a
corpus luteum, immunoreactive SHBG was
found in the large luteal cells, whereas the
small luteal cells were only weakly and incon-
sistently stained. This luteal SHBG expression
profile was in accordance with the above-
mentioned results from the antral follicles, in
that large luteal cells were classically thought
to originate in the granulosa cells, while small
luteal cells differentiated from thecal cells
(Sanders and Stouffer, 1997).
In summary, SHBG has now evolved from
a basic circulating transport protein to a lo-
cally produced and secreted cell mediator in
sex steroid-sensitive tissues. In the human fol-
licle, SHBG is differentially expressed during
folliculogenesis and, after ovulation, in the
corpus luteum. Granulosa-lutein cells are one
of the possible sources of SHBG in the ovary.
Follicular fluid SHBG may, therefore, origi-
nate not only in the serum, but also in a local
secretion by the granulosa cells surrounding
the follicular antrum. The role that SHBG
plays in ovarian physiology still remains elu-
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sive. A major breakthrough may be expected
from animal models, where the SHBG gene
would have been deactivated. However, until
now, no knock-out experience has been re-
ported. Thus, further knowledge about this
protein will rely mainly upon in vitro studies.
Our group is currently investigating the possi-
ble roles of SHBG in human granulosa-lutein
cells in vitro.
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